Enhabit, Inc. (NASDAQ:EHAB) reported an insider sale by Chief Accounting Officer Collin McQuiddy on March 11, 2026. McQuiddy sold 1,403 shares of the company s common stock at a price of $13.61 per share, bringing the total value of the transaction to $19,094.
The sale occurred while the share price sat near a 52-week high of $13.68. Over the preceding 12 months the stock has returned 59% to holders. According to InvestingPro analysis cited in company reporting, the stock currently appears overvalued when measured against its Fair Value.
Following the disposition, McQuiddy s direct holdings in Enhabit total 3,991 shares. For investors seeking more detailed valuation and performance analysis, a Pro Research Report covering Enhabit is available through InvestingPro, which offers similar reports for 1,400+ other U.S. equities.
Separately, Enhabit Home Health & Hospice disclosed a definitive agreement under which private equity firm Kinderhook Industries will acquire the company for $13.80 per share in cash. That purchase price implies a valuation for Enhabit of approximately $1.1 billion.
The buyout announcement has triggered a series of analyst responses and price-target revisions. TD Cowen downgraded the stock from Buy to Hold and set a new price target at $13.80. UBS moved its rating to Neutral from Buy and aligned its price target to the $13.80 acquisition level. Jefferies also reduced its recommendation to Hold from Buy and set a $13.80 price target.
Conversely, Leerink Partners and Truist Securities adjusted their price targets upward to $13.80 while retaining their respective Market Perform and Hold ratings. These actions demonstrate the market and sell-side reaction to the acquisition price, which the reporting notes values Enhabit at multiple times the company's estimated 2026 EBITDA.
The sequence of an insider sale, a near-52-week-high trading level, and a cash acquisition priced at $13.80 per share has produced a narrow and specific market narrative: the company s quoted market value is closely tied to the agreed acquisition price, and several analysts have recalibrated their views accordingly.